Indian council medical research English news | Indian council medical research, Latest News & Live Updates in English | English News (Latest English News) at Lokmattimes.com

New Delhi, Sep 12 Ever since it was revealed that convalescent plasma (CP) therapy could help treat severely-ill COVID-19patients, it was hailed as a magic bullet for people whose hopes were dashed in the absence of a vaccine or a proven drug. However, recent studies have raised questions about the efficacy of plasma therapy.A few days ago, the Indian Council of Medical Research (ICMR) published the result of a trial conducted across 39 hospitals in the country to determine if the plasma therapy reduces COVID-19 fatality or slows the progression of the disease. The study could not establish either scenario.A month ago, All India Institute of Medical Sciences (AIIMS) had also conducted a trial for the plasma therapy on COVID-19 patients. The trial results revealed that the therapy did not show much clinical benefit in reducing fatality risk caused due to the virus.While the subsequent research proves that plasma therapy's efficacy is minimal in moderate and severe COVID-19 patients, the doctors still believe that it is proving helpful in the treatment.Dr Pankaj Solanki, who runs Dharamveer Solanki Hospital, a COVID-19 facility in New Delhi, believes that one should not see plasma therapy as an alternative to the vaccine. He said that its efficacy is proven in treating patients suffering from infectious diseases like EBOLA. "The concept of convalescent plasma is simple. Patients who recover from an infectious disease often produce antibodies that can protect against later infections with the same viral infection. This immunity can be transferred by giving serum to those at risk of infection. It has been used for viral infections like EBOLA, MERS, Spanish Flu, SARS, and measles with some success," he said."Now coming to the benefits, it is very well tolerated, reduces hospital stay time, and promotes the early discharge of patients. Till we do not have any definitive treatment or vaccine, I would recommend the continuous use of this therapy," added Dr Solanki.Dr Gyan Bharti, a pulmonologist at Columbia Asia Hospital in Ghaziabad, said that plasma therapy is the best supportive medium to generate against the virus in the absence of a vaccine. "There is a group of patients who benefited from plasma therapy. It is one of the best supportive ways to fight with COVID as it generates antibodies against the virus. Till the vaccine arrives, the plasma therapy remains the best medium to insert antibodies inside the body of an infected person," he said."A recent ICMR study revealed no benefit of Convalescent Plasma therapy in COVID patients who are moderate to severely ill. However, neither we have any definite treatment nor a vaccine for COVID. In such a situation, each medication, whether it is Fabipiravir, Tocilizumab, Remdesivir, or Convalescent Plasma Therapy, has a different response on a different patient," Dr Bharti added.Meanwhile, Dr Aashish Chaudhry, Managing Director of Aakash Healthcare Super-speciality Hospital in New Delhi, said that plasma therapy has proven to be a potential modality for treatment for COVID. However, he also said that more studies would be required to come to any conclusion."COVID-19 is a new disease, and all efforts and treatment are directed for patient improvement, plasma therapy is one potential modality of treatment, but more scientific evidence and multicentric trials are still needed before we can completely write off the efficacy of plasma therapy in managing COVID-19," added Dr Chaudhry.( With inputs from IANS )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Indian Council Medical ResearchFOLLOW

Indian council medical research, Latest News

India's COVID-19 case tally crossed 53-lakh mark with a spike of 93,337 new cases and 1,247 deaths in the last 24 hours, according to the Union Ministry of Health and Family Welfare on Saturday. ...

New Delhi, Sep 18 With a massive spike of 96,424 new cases and 1,172 deaths in the last 24 ... ...

India's COVID-19 case tally crossed 52-lakh mark with a spike of 96,424 new cases and 1,174 deaths in the last 24 hours, said Union Ministry of Health & Family Welfare on Friday. ...

The Indian Council of Medical Research (ICMR), the apex body at forefront of formulating the COVID-19 testing strategy in India has crossed six crore-mark on Wednesday. ...

The Indian Council of Medical Research (ICMR) on Thursday launched an online course, Prescribing Skills, for Indian Medical Graduates (IMG) on the occasion of Patient Safety Day to improve prescription practices. ...

With 94,372 new COVID-19 cases in India, the national coronavirus count reached over the 47-lakh, as per the Union Ministry of Health and Family Welfare on Sunday. ...

India in the last 24 hours reported 94,372 new COVID-19 cases taking the national coronavirus tally beyond the 47-lakh mark, as per the Union Ministry of Health and Family Welfare on Sunday. ...

New Delhi, Sep 12 Ever since it was revealed that convalescent plasma (CP) therapy could help treat severely-ill ... ...